Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes

Author:

Tang Yu1ORCID,Zhang Yu-Jing2,Zhang Na3,Shi Mei4,Wen Ge5,Cheng Jing6,Wang Hong-Mei7,Liu Min8,Wang Xiao-Hu9,Guo Qi-Shuai10,Wu Hong-Fen11,Ma Chang-Ying12,Jin Jing1ORCID,Liu Yue-Ping1,Song Yong-Wen1,Fang Hui1,Ren Hua1,Wang Shu-Lian1,Li Ye-Xiong1ORCID

Affiliation:

1. State Key Laboratory of Molecular Oncology and Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Radiation Oncology Sun Yat‐sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine Guangzhou China

3. Department of Radiation Oncology Cancer Hospital of China Medical UniversityLiaoning Cancer Hospital and Institute Shenyang China

4. Department of Radiation Oncology Xijing HospitalFourth Military Medical University Xi'an China

5. Department of Radiation Oncology The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China

6. Department of Breast Oncology Union HospitalTongji Medical CollegeHuazhong University of Science and Technology Wuhan China

7. Department of Radiation Oncology Nanfang HospitalSouthern Medical University Guangzhou China

8. Department of Radiation Oncology First Hospital of Jilin University Changchun China

9. Department of Radiation Oncology Gansu Cancer Hospital Lanzhou China

10. Department of Radiation Oncology Chongqing University Cancer HospitalChongqing Cancer InstituteChongqing Cancer Hospital Chonqing China

11. Department of Radiation Oncology Jilin Cancer Hospital Changchun China

12. Department of Radiation Oncology First Hospital of Qiqihaer Qiqihaer China

Funder

Chinese Academy of Medical Sciences

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3